Industry News
“Australian 11” of medical research: GSK Award for Research Excellence finalists announced
A selection of Australia’s leading medical researchers have been declared finalists in the 2012 GlaxoSmithKline Award for Research Excellence, with the winner to be announced on September 11. [ + ]
Universal Biosensors gets second $1.5m payment
Universal Biosensors (ASX:UBI) has earned a second $1.5 million milestone payment from Siemens Healthcare, seven weeks after receiving the first. [ + ]
AAMRI calls for government to spur biotech commercialisation
The government has a significant role to play in helping Australia’s world class medical research be translated into genuine health and economic benefits, says the Association of Australian Medical Research Institutes (AAMRI). [ + ]
Technology partnership to tackle society’s big challenges
The University of Western Australia has teamed up with measurement technology company Agilent Technologies, committing to a five-year collaboration that will enable the development of groundbreaking applications in life sciences. [ + ]
Investment event of the year calls for expressions of interest
AusBiotech invites your expression of interest for the opportunity to present at the Australasian Life Science Investment Summit (ALSIS) 2012 as one of 40 of Australasia’s most promising biotechnology companies. [ + ]
BREVAGen receives approval to sell in California
Genetic Technologies (ASX:GTG) continues its push into the US with BREVAGen, with it gaining approval to sell into California. [ + ]
CoDa raises NZ$25m to fund wound treatment
NZ biotech CoDa Therapeutics has received a NZ$24.5 million funding injection from a Russian investor, to help continue commercialisation of wound therapy Nexagon. [ + ]
Tracing the ‘great, great grandmothers’ of the chicken world
Dr Alice Storey, an archaeologist at the University of New England, is tracing the global migration routes of domestic chickens back through thousands of years towards their origins in the jungles of South-East Asia. [ + ]
Mesoblast eyes human trials of stem cell treatment for rheumatoid arthritis
Animal trials of Mesoblast's (ASX:MSB) mesenchymal stem cells in rheumatoid arthritis (RA) have encouraged the company press on with an FDA application for a phase II trial. [ + ]
AtCor files FDA application for cardiovascular monitor
AtCor Medical (ASX:ACG) has submitted an application for approval to market its updated SphygmoCor XCEL cardiovascular monitoring system in the US. [ + ]
Positive results from C-Pulse follow-up
Sunshine Heart (ASX:SHC) has released promising 12-month follow-up data from the feasibility trial for its C-Pulse Heart Assist System, as the trial heads into the two-year follow-up stage. [ + ]
Bioniche canine cancer product approved in NA
US and Canadian regulators have approved Immunocidin, the first of two canine cancer products developed by Bioniche (ASX:BNC). [ + ]
Future Fellowships funding supports Australia’s best mid-career researchers
The Minister for Science and Research, Senator Chris Evans, today announced 209 Future Fellowships totalling $151 million to provide research opportunities to some of the world’s best mid-career researchers. [ + ]
Putting smokers’ oxidative stress levels under the microscope
A new study investigating the effectiveness of live blood analysis (LBA) as a tool to measure oxidative stress is being conducted at Southern Cross University and smokers are being invited to take part. [ + ]
AusIndustry to hold registration workshops on Tax Incentive
AusIndustry is holding registration ready workshops to help companies better understand and register for the R&D Tax Incentive. [ + ]
